IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9849162 B1

PDFFull Text
Date of Patent:
Dec. 26, 2017

Filed:

Apr. 02, 2013

Treatment with factor vii-albumin fusion protein

Applicants:

David J. Ballance, Berwyn, PA (US);

Darrell Sleep, West Bridgford, GB;

Inventors:

David J. Ballance, Berwyn, PA (US);

Darrell Sleep, West Bridgford, GB;

Assignee:

ALBUMEDIX A/S, Lyngby, DK;

Attorney:

Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Primary Examiner:

Hope Robinson

Int. Cl.
CPC ...
A61K 38/48 (2006.01); A61K 9/00 (2006.01); A61K 38/21 (2006.01); A61K 38/38 (2006.01); C07K 14/56 (2006.01); C07K 14/61 (2006.01); C07K 14/62 (2006.01); C07K 14/65 (2006.01); C07K 14/705 (2006.01); C07K 14/715 (2006.01); C07K 14/76 (2006.01); C07K 14/765 (2006.01); C12N 15/62 (2006.01); C12N 9/96 (2006.01); A61K 47/48 (2006.01); A61K 47/42 (2017.01); A61K 48/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 38/4846 (2013.01); A61K 9/0019 (2013.01); A61K 38/21 (2013.01); A61K 38/212 (2013.01); A61K 38/38 (2013.01); A61K 47/48338 (2013.01); C07K 14/56 (2013.01); C07K 14/61 (2013.01); C07K 14/62 (2013.01); C07K 14/65 (2013.01); C07K 14/705 (2013.01); C07K 14/7151 (2013.01); C07K 14/76 (2013.01); C07K 14/765 (2013.01); C12N 9/96 (2013.01); C12N 15/62 (2013.01); A01K 2217/05 (2013.01); A61K 47/42 (2013.01); A61K 48/00 (2013.01); A61K 2039/54 (2013.01); C07K 2319/00 (2013.01); C07K 2319/21 (2013.01); C07K 2319/31 (2013.01); C07K 2319/50 (2013.01); C07K 2319/75 (2013.01);
Abstract

The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disorders or conditions using albumin fusion proteins of the invention.

Find Patent Forward Citations

Loading…